Vectalys Alternatives & Competitors
8 companies similar to Vectalys — Pioneering excellence in gene delivery to empower groundbreaking scientific disc...
Companies similar to Vectalys
Altheia Science
Altheia Science develops treatments for autoimmune diseases and cancer using innovative to...
Edity Therapeutics
Using human immune cells to deliver therapeutic proteins
Prolific Machines
Illuminating biology's limitless potential
COARE Biotechnology
Pioneering targeted therapies to eradicate solid tumor cancers and alleviate patient suffe...
Track all Vectalys competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
TreeFrog Therapeutics
Cell Therapy for All
Anocca
Engineered Immunity
Elixirgen Therapeutics, Inc.
Reimagine the Power of RNA
NeuCyte
Decoding CNS Drug Discovery with SynFire® iP
About Vectalys
Vectalys is a biotech startup founded in 2005 by Pascale Bouillé, specializing in gene delivery through lentiviral vectors. With a dedicated team of 25 full-time employees, Vectalys provides lentiviral vectors, cell models, molecular biology strategies, and project support to scientists globally. The company's advanced...
Gene Delivery, Lentiviral Vectors, Biotech Company, Molecular Biology, Scientific Discovery, Therapeutic Development, Cell Models, Proprietory Technology, Transduction Efficiency, Custom Vectors, Fluorescent Proteins, Bioluminescent Proteins, Gene Editing, Primary Cells, Stem Cells
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Vectalys and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Vectalys on 11 Sep 2024. The 8 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.